- Michael Ehlers joins Formation Bio to lead R&D; Black Diamond co-founder dies at 67Michael Ehlers left his CEO role at Ascidian Therapeutics, the exon editing company he co-founded, to run R&D at the AI biotech Formation Bio. It’s not often that biotech executives leave ...Endpoints · 3d ago↗ source
- STAT+: Merck strikes voluntary licensing deals in poor countries for an experimental HIV prevention pillMerck is striking licensing deals for its experimental HIV prevention pill in hope of getting wide-scale production started quickly.STAT · 3d ago↗ source
- Sanofi nixes Kymab-originated OX40L antibody in atopic dermatitisSanofi has decided to stop working on a drug for eczema it had hoped would be a successor to its immunological megablockbuster Dupixent. The French pharma said that it won’t seek ...